Rocio Finol-Urdaneta

Affiliations: 
2016- University of Wollongong, Australia 
Google:
"Rocio Finol-Urdaneta"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Hackney CM, Flórez Salcedo P, Mueller E, et al. (2023) A previously unrecognized superfamily of macro-conotoxins includes an inhibitor of the sensory neuron calcium channel Cav2.3. Plos Biology. 21: e3002217
Finol-Urdaneta RK, Zhorov BS, Baden DG, et al. (2023) Brevetoxin versus Brevenal Modulation of Human Nav1 Channels. Marine Drugs. 21
Boccaccio A, Finol-Urdaneta RK. (2023) Redox Bridling of GIRK Channel Activity. Function (Oxford, England). 4: zqad027
Finol-Urdaneta RK, McArthur JR, Aboelela A, et al. (2023) Automated Patch Clamp Screening of Amiloride and 5-,-Hexamethyleneamiloride Analogs Identifies 6-Iodoamiloride as a Potent Acid-Sensing Ion Channel Inhibitor. Molecular Pharmaceutics
Bye LJ, Finol-Urdaneta RK, Adams DJ. (2023) Calcium Imaging of Non-adherent Cells. Methods in Molecular Biology (Clifton, N.J.). 2644: 361-369
Bye LJ, Finol-Urdaneta RK, Tae HS, et al. (2023) Nicotinic acetylcholine receptors: Key targets for attenuating neurodegenerative diseases. The International Journal of Biochemistry & Cell Biology. 157: 106387
Maksemous N, Blayney CD, Sutherland HG, et al. (2022) Investigation of Cav3.3 Dysfunction in Hemiplegic Migraine. Frontiers in Molecular Neuroscience. 15: 892820
McArthur JR, Wen J, Hung A, et al. (2022) µ-Theraphotoxin Pn3a inhibition of Ca3.3 channels reveals a novel isoform-selective drug binding site. Elife. 11
Finol-Urdaneta RK, Ziegman R, Dekan Z, et al. (2022) Multitarget nociceptor sensitization by a promiscuous peptide from the venom of the King Baboon spider. Proceedings of the National Academy of Sciences of the United States of America. 119
Bony AR, McArthur JR, Finol-Urdaneta RK, et al. (2021) Analgesic α-conotoxins modulate native and recombinant GIRK1/2 channels via GABA receptor activation and reduce neuroexcitability. British Journal of Pharmacology
See more...